Victor-Felix Mautner Selected Research

Victor-Felix Mautner Research Topics

Disease

16	Neoplasms (Cancer) 01/2023 - 08/2004
10	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2022 - 07/2007
6	Plexiform Neurofibroma 01/2023 - 08/2004
5	Acoustic Neuroma (Acoustic Neurinoma) 10/2020 - 01/2010
4	Neurilemmoma (Schwannoma) 01/2023 - 01/2016
4	Neurofibrosarcoma (MPNST) 01/2023 - 01/2016
4	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2015 - 08/2004
4	Neurofibromatoses (Neurofibromatosis) 02/2014 - 08/2004
3	Neurofibroma 01/2023 - 08/2004
3	Schwannomatosis 01/2022 - 01/2017
3	Cataract (Cataracts) 12/2008 - 07/2007
2	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 01/2023 - 01/2020
2	Glioma (Gliomas) 09/2020 - 02/2019
2	Hamartoma 12/2008 - 07/2007
1	Residual Neoplasm 10/2020
1	Paronychia 09/2020
1	Exanthema (Rash) 09/2020
1	Lipoma (Lipomata) 01/2020
1	Fabry Disease (Fabry's Disease) 11/2018
1	Disease Progression 11/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Proteinuria 12/2015
1	Hypertension (High Blood Pressure) 12/2015
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2013
1	Learning Disabilities (Learning Disability) 10/2013
1	Polyneuropathies (Polyneuropathy) 04/2013
1	Astrocytoma (Pilocytic Astrocytoma) 12/2012
1	Ependymoma 12/2012
1	Carcinogenesis 09/2012
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 12/2008
1	Nervous System Neoplasms (Neoplasms, Nervous System) 10/2008
1	Epiretinal Membrane (Epiretinal Membranes) 10/2008
1	Microaneurysm 10/2008

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2010
3	Retinaldehyde (Retinal)IBA 12/2008 - 07/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2020 - 02/2020
2	Neurofibromin 1 (Neurofibromin)IBA 01/2016 - 10/2013
2	Neurofibromin 2 (Merlin)IBA 02/2014 - 04/2013
1	Atrial Natriuretic Factor (ANF)IBA 01/2023
1	Uvitex SWN (SWN)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 09/2020
1	trametinibIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 07/2020
1	Mechanistic Target of Rapamycin Complex 2IBA 02/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2020
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 02/2020
1	AZD 6244IBA 02/2020
1	MK 2206IBA 02/2020
1	MTOR InhibitorsIBA 02/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 02/2019
1	EnzymesIBA 11/2018
1	Mutant Proteins (Protein, Mutant)IBA 01/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2015
1	LigandsIBA 02/2014
1	Neuregulin-1 (Neuregulin 1)IBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 02/2014
1	Lovastatin (Mevacor)FDA LinkGeneric 10/2013
1	Protein Isoforms (Isoforms)IBA 04/2013
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2012
1	Untranslated RNA (Noncoding RNA)IBA 10/2012
1	Nonsense Codon (Nonsense Mutation)IBA 12/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2007
1	Oral ContraceptivesIBA 02/2005
1	Contraceptive Agents (Contraceptives)IBA 02/2005
1	Estrogens (Estrogen)FDA Link 02/2005
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2005
1	Progesterone FDA LinkGeneric 02/2005
1	Progestins (Progestagens)IBA 02/2005
1	Mitochondrial DNA (mtDNA)IBA 08/2004

Therapy/Procedure

5	Therapeutics 01/2020 - 01/2010
3	Drug Therapy (Chemotherapy) 02/2019 - 02/2010
2	Decompression 10/2020 - 08/2019
2	Ligation 01/2020 - 03/2009
1	Lasers (Laser) 03/2021
1	Drug Tapering 09/2020
1	Enzyme Replacement Therapy 11/2018
1	Nerve Crush 01/2016
1	Hormonal Contraception 02/2005